Market Cap 3.31B
Revenue (ttm) 3.71B
Net Income (ttm) 331.00M
EPS (ttm) N/A
PE Ratio 8.47
Forward PE 9.46
Profit Margin 8.91%
Debt to Equity Ratio 0.66
Volume 467,100
Avg Vol 437,890
Day's Range N/A - N/A
Shares Out 53.20M
Stochastic %K 35%
Beta 0.90
Analysts Hold
Price Target $72.40

Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions. The company also provides specialty carbons for use in inks, coatings...

Industry: Specialty Chemicals
Sector: Basic Materials
Phone: 617 345 0100
Fax: 617 342 6103
Address:
Two Seaport Lane, Suite 1400, Boston, United States
PrivateProfiteer
PrivateProfiteer Nov. 15 at 1:31 AM
$CBT is currently trading at $62.22, significantly below its 30-day moving average (MA30) of $67.95 and 50-day moving average (MA50) of $71.89, indicating a bearish trend. The RSI at 20.92 suggests that the stock is oversold, which may lead to a potential reversal or bounce in the short term. The recent 60-day high of $83.71 and low of $58.99 further highlight the volatility and potential for a rebound from the current price. Suggested trade plan: - Entry: $62.50 (slightly above current close to confirm upward momentum) - Stop: $58.50 (below the 60D low to limit losses) - Target 1: $67.00 (near MA30) - Target 2: $71.00 (near MA50) This plan leverages the oversold condition while acknowledging the bearish trend indicated by the moving averages. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 5:04 AM
$CBT is currently trading at $62.22, significantly below its 30-day moving average (MA30) of $67.95 and 50-day moving average (MA50) of $71.89, indicating a bearish trend. The RSI at 20.92 suggests that the stock is oversold, which may lead to a potential reversal or bounce in the short term. The recent 60-day high of $83.71 and low of $58.99 further highlight the volatility and potential for a rebound from the current price. Suggested trade plan: - Entry: $62.50 (slightly above current close to confirm upward momentum) - Stop: $58.50 (below the 60D low to limit losses) - Target 1: $67.00 (near MA30) - Target 2: $71.00 (near MA50) This plan leverages the oversold condition while acknowledging the bearish trend indicated by the moving averages. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 3:10 AM
$CBT is currently trading at $61.41, significantly below the 30-day MA of $68.85 and the 50-day MA of $72.64, indicating a bearish trend. The RSI at 18.26 suggests that the stock is oversold, which could lead to a potential reversal or short-term bounce. However, with the recent price action, the stock remains under pressure, having approached the 60-day low of $58.99. Market context indicates a strong downward momentum, as the price is closer to the lower end of its 60-day range. A suggested entry point could be around $60, with a stop loss set at $58 to manage risk. Targets could be set at $64 (near the 30-day MA) and $68 (targeting a retracement towards the 50-day MA). This plan allows for a cautious approach, balancing the potential for a rebound against the prevailing bearish sentiment. https://privateprofiteers.com
0 · Reply
SuperGreenToday
SuperGreenToday Nov. 12 at 5:11 AM
$CBT Share Price: $61.40 Contract Selected: Apr 17, 2026 $65 Calls Buy Zone: $2.51 – $3.10 Target Zone: $4.76 – $5.82 Potential Upside: 79% ROI Time to Expiration: 156 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 2:46 AM
$CBT is currently trading at $61.41, significantly below the 30-day MA of $68.85 and the 50-day MA of $72.64, indicating a bearish trend. The RSI at 18.26 suggests that the stock is oversold, which could lead to a potential reversal or short-term bounce. However, with the recent price action, the stock remains under pressure, having approached the 60-day low of $58.99. Market context indicates a strong downward momentum, as the price is closer to the lower end of its 60-day range. A suggested entry point could be around $60, with a stop loss set at $58 to manage risk. Targets could be set at $64 (near the 30-day MA) and $68 (targeting a retracement towards the 50-day MA). This plan allows for a cautious approach, balancing the potential for a rebound against the prevailing bearish sentiment. https://privateprofiteers.com
0 · Reply
Estimize
Estimize Nov. 11 at 9:00 PM
Wall St is expecting 1.44 EPS for $CBT Q1 [Reporting 02/09 AMC] http://www.estimize.com/intro/cbt?chart=historical&metric_name=eps&utm_cont
0 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice Nov. 10 at 5:37 PM
$CBT I like this long term however this is a major tax sell candidate Having said that expect more downside for the remainder of the year …
0 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice Nov. 7 at 1:03 PM
$CBT If there was ever a stock that would be taken out by private equity it’s this one They make a lot of $$ and they generate loads of cash… There were lots of positive nuggets on the call it’s just that a portion of their business is in a trough however performance chemicals is growing high double digits
0 · Reply
IN0V8
IN0V8 Nov. 6 at 5:04 AM
$CBT Opportunity UBS cuts target price to $65 from $82
0 · Reply
JarvisFlow
JarvisFlow Nov. 5 at 11:48 PM
UBS updates rating for Cabot ( $CBT ) to Neutral, target set at 82 → 65.
0 · Reply
Latest News on CBT
Cabot Corporation Board Declares Dividend

Nov 13, 2025, 6:30 PM EST - 1 day ago

Cabot Corporation Board Declares Dividend


Is It Time To Buy Cabot Stock?

Nov 6, 2025, 12:20 PM EST - 8 days ago

Is It Time To Buy Cabot Stock?


Cabot Corporation (CBT) Q4 2025 Earnings Call Transcript

Nov 4, 2025, 12:56 PM EST - 10 days ago

Cabot Corporation (CBT) Q4 2025 Earnings Call Transcript


Cabot Corporation (CBT) Q3 2025 Earnings Call Transcript

Aug 5, 2025, 9:59 AM EDT - 3 months ago

Cabot Corporation (CBT) Q3 2025 Earnings Call Transcript


Cabot Corp Reports Third Quarter Fiscal 2025 Results

Aug 4, 2025, 4:32 PM EDT - 3 months ago

Cabot Corp Reports Third Quarter Fiscal 2025 Results


Cabot: An Interesting Specialty Chemical Play

Jul 28, 2025, 8:17 AM EDT - 3 months ago

Cabot: An Interesting Specialty Chemical Play


Ex-Dividend Reminder: Cabot, Dow And Stepan

May 28, 2025, 11:50 AM EDT - 6 months ago

Ex-Dividend Reminder: Cabot, Dow And Stepan

DOW SCL


Cabot: Uphill Battle Remains Following Q2 Earnings Release

May 13, 2025, 11:31 AM EDT - 6 months ago

Cabot: Uphill Battle Remains Following Q2 Earnings Release


Cabot Corporation (CBT) Q2 2025 Earnings Call Transcript

May 11, 2025, 9:40 AM EDT - 6 months ago

Cabot Corporation (CBT) Q2 2025 Earnings Call Transcript


Cabot Corp Reports Second Quarter Fiscal 2025 Results

May 5, 2025, 4:30 PM EDT - 6 months ago

Cabot Corp Reports Second Quarter Fiscal 2025 Results


Cabot Corporation Board Increases Dividend

May 5, 2025, 4:26 PM EDT - 6 months ago

Cabot Corporation Board Increases Dividend


Cabot Corporation: Reinforcing Positive Shareholder Value

Feb 13, 2025, 5:55 AM EST - 9 months ago

Cabot Corporation: Reinforcing Positive Shareholder Value


Cabot Corporation (CBT) Q1 2025 Earnings Call Transcript

Feb 4, 2025, 12:01 PM EST - 10 months ago

Cabot Corporation (CBT) Q1 2025 Earnings Call Transcript


Cabot Corp Reports First Quarter Fiscal 2025 Results

Feb 3, 2025, 4:31 PM EST - 10 months ago

Cabot Corp Reports First Quarter Fiscal 2025 Results


Cabot Corporation to Announce First Quarter 2025 Operating Results

Jan 10, 2025, 1:03 PM EST - 11 months ago

Cabot Corporation to Announce First Quarter 2025 Operating Results


Cabot Corporation (CBT) Q4 2024 Earnings Call Transcript

Nov 5, 2024, 1:08 PM EST - 1 year ago

Cabot Corporation (CBT) Q4 2024 Earnings Call Transcript


Cabot Corporation to Host 2024 Investor Day

Oct 7, 2024, 3:09 PM EDT - 1 year ago

Cabot Corporation to Host 2024 Investor Day


Cabot Corporation (CBT) Q3 2024 Earnings Call Transcript

Aug 6, 2024, 11:31 AM EDT - 1 year ago

Cabot Corporation (CBT) Q3 2024 Earnings Call Transcript


Cabot Corp Reports Third Quarter Fiscal 2024 Results

Aug 5, 2024, 4:34 PM EDT - 1 year ago

Cabot Corp Reports Third Quarter Fiscal 2024 Results


13 Upcoming Dividend Increases

May 27, 2024, 10:31 PM EDT - 1 year ago

13 Upcoming Dividend Increases

ACNB ASH DE EVR FDS HBB HY


Cabot Corporation (CBT) Q2 2024 Earnings Call Transcript

May 7, 2024, 11:25 AM EDT - 1 year ago

Cabot Corporation (CBT) Q2 2024 Earnings Call Transcript


Cabot Corp Reports Second Quarter Fiscal 2024 Results

May 6, 2024, 4:31 PM EDT - 1 year ago

Cabot Corp Reports Second Quarter Fiscal 2024 Results


PrivateProfiteer
PrivateProfiteer Nov. 15 at 1:31 AM
$CBT is currently trading at $62.22, significantly below its 30-day moving average (MA30) of $67.95 and 50-day moving average (MA50) of $71.89, indicating a bearish trend. The RSI at 20.92 suggests that the stock is oversold, which may lead to a potential reversal or bounce in the short term. The recent 60-day high of $83.71 and low of $58.99 further highlight the volatility and potential for a rebound from the current price. Suggested trade plan: - Entry: $62.50 (slightly above current close to confirm upward momentum) - Stop: $58.50 (below the 60D low to limit losses) - Target 1: $67.00 (near MA30) - Target 2: $71.00 (near MA50) This plan leverages the oversold condition while acknowledging the bearish trend indicated by the moving averages. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 5:04 AM
$CBT is currently trading at $62.22, significantly below its 30-day moving average (MA30) of $67.95 and 50-day moving average (MA50) of $71.89, indicating a bearish trend. The RSI at 20.92 suggests that the stock is oversold, which may lead to a potential reversal or bounce in the short term. The recent 60-day high of $83.71 and low of $58.99 further highlight the volatility and potential for a rebound from the current price. Suggested trade plan: - Entry: $62.50 (slightly above current close to confirm upward momentum) - Stop: $58.50 (below the 60D low to limit losses) - Target 1: $67.00 (near MA30) - Target 2: $71.00 (near MA50) This plan leverages the oversold condition while acknowledging the bearish trend indicated by the moving averages. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 3:10 AM
$CBT is currently trading at $61.41, significantly below the 30-day MA of $68.85 and the 50-day MA of $72.64, indicating a bearish trend. The RSI at 18.26 suggests that the stock is oversold, which could lead to a potential reversal or short-term bounce. However, with the recent price action, the stock remains under pressure, having approached the 60-day low of $58.99. Market context indicates a strong downward momentum, as the price is closer to the lower end of its 60-day range. A suggested entry point could be around $60, with a stop loss set at $58 to manage risk. Targets could be set at $64 (near the 30-day MA) and $68 (targeting a retracement towards the 50-day MA). This plan allows for a cautious approach, balancing the potential for a rebound against the prevailing bearish sentiment. https://privateprofiteers.com
0 · Reply
SuperGreenToday
SuperGreenToday Nov. 12 at 5:11 AM
$CBT Share Price: $61.40 Contract Selected: Apr 17, 2026 $65 Calls Buy Zone: $2.51 – $3.10 Target Zone: $4.76 – $5.82 Potential Upside: 79% ROI Time to Expiration: 156 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 2:46 AM
$CBT is currently trading at $61.41, significantly below the 30-day MA of $68.85 and the 50-day MA of $72.64, indicating a bearish trend. The RSI at 18.26 suggests that the stock is oversold, which could lead to a potential reversal or short-term bounce. However, with the recent price action, the stock remains under pressure, having approached the 60-day low of $58.99. Market context indicates a strong downward momentum, as the price is closer to the lower end of its 60-day range. A suggested entry point could be around $60, with a stop loss set at $58 to manage risk. Targets could be set at $64 (near the 30-day MA) and $68 (targeting a retracement towards the 50-day MA). This plan allows for a cautious approach, balancing the potential for a rebound against the prevailing bearish sentiment. https://privateprofiteers.com
0 · Reply
Estimize
Estimize Nov. 11 at 9:00 PM
Wall St is expecting 1.44 EPS for $CBT Q1 [Reporting 02/09 AMC] http://www.estimize.com/intro/cbt?chart=historical&metric_name=eps&utm_cont
0 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice Nov. 10 at 5:37 PM
$CBT I like this long term however this is a major tax sell candidate Having said that expect more downside for the remainder of the year …
0 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice Nov. 7 at 1:03 PM
$CBT If there was ever a stock that would be taken out by private equity it’s this one They make a lot of $$ and they generate loads of cash… There were lots of positive nuggets on the call it’s just that a portion of their business is in a trough however performance chemicals is growing high double digits
0 · Reply
IN0V8
IN0V8 Nov. 6 at 5:04 AM
$CBT Opportunity UBS cuts target price to $65 from $82
0 · Reply
JarvisFlow
JarvisFlow Nov. 5 at 11:48 PM
UBS updates rating for Cabot ( $CBT ) to Neutral, target set at 82 → 65.
0 · Reply
ZacksResearch
ZacksResearch Nov. 5 at 1:32 PM
$CBT stumbled in Q4 📉 Earnings and sales both fell year over year, missing estimates as softer demand and lower volumes dragged results down. Full earnings breakdown here 👉 https://www.zacks.com/stock/news/2785476/cabots-q4-earnings-and-sales-miss-estimates-decline-yy?cid=sm-stocktwits-2-2785476-teaser-19486&ADID=SYND_STOCKTWITS_TWEET_2_2785476_TEASER_19486
0 · Reply
ZacksResearch
ZacksResearch Nov. 5 at 12:32 PM
Earnings miss for $CBT — what's dragging it down? 🤔 Q4 adjusted EPS of $1.70 missed the Zacks Consensus Estimate of $1.72, with net sales falling around 10.2% from the prior-year quarter to $899M, below expectations 👎. Weakness in Reinforcement Materials continues to apply pressure. Complete analysis here 👉 https://www.zacks.com/stock/news/2785476/cabots-q4-earnings-and-sales-miss-estimates-decline-yy?cid=sm-stocktwits-2-2785476-body-19485&ADID=SYND_STOCKTWITS_TWEET_2_2785476_BODY_19485
0 · Reply
Pedja1980
Pedja1980 Nov. 5 at 1:10 AM
$CBT this should be on buy list
1 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice Nov. 3 at 10:07 PM
$CBT CEO should be calling private equity and take their shareholders out of misery…Terribly managed company…. They keep investing shareholder $$ into ESG instead of concentrating on maximizing shareholder return
1 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice Nov. 3 at 9:59 PM
$CBT When the third highlight is “sustainability report” this is a WOKE company
0 · Reply
grnstock
grnstock Nov. 3 at 9:29 PM
$CBT Oh man, this one has a PE around 8. So undervalued. GL
0 · Reply
smartkarma
smartkarma Oct. 26 at 8:11 PM
$CBT | Primer: Cabot Corp (CBT US) - Oct 2025 "Cabot Corp is a leading global specialty chemicals and performance materials company, holding strong market positions in its core segments of..." - αSK (Smartkarma) Read more: https://www.smartkarma.com/insights/primer-cabot-corp-cbt-us-oct-2025
0 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice Oct. 22 at 3:38 PM
$CBT This looks like a sympathy bounce the technicals are very bad .. A massive head and shoulder pattern
0 · Reply
Pedja1980
Pedja1980 Oct. 15 at 1:55 PM
$CBT worth start bulding the position With some expectation that we might see also 10-15% cheaper prices would be wise choice This looks like its trading very detached from fundamental reality and majority of the bad news are priced in My few cents .. ✌️
1 · Reply
Pedja1980
Pedja1980 Oct. 15 at 2:04 AM
$CBT looks finally like reversal day This stock is way oversold
1 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice Oct. 14 at 5:16 PM
$CBT Message to the CEO Your stock is trading at 9x …since the market has no confidence perhaps you should be considering PE deal to take your shareholders out of misery
0 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice Oct. 14 at 2:55 PM
$CBT Undervalued but the majority of the news here is all ESG… They spend a lot of time and $$ on this nonsense … WOKE company
0 · Reply